Metropolitan Life Insurance CO Bioventus Inc. Transaction History

Metropolitan Life Insurance CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Jun 14, 2023	BUY	$6.54 - $9.08 $14,715 - $20,430	2,250 New	2,250 $15.8 Million
Q2 2022 Jun 20, 2023	BUY	$6.82 - $13.82 $15,345 - $31,095	2,250 New	2,250 $15,000
Q1 2022 Jun 20, 2023	BUY	$11.65 - $15.28 $26,212 - $34,380	2,250 New	2,250 $31,000
Q1 2022 Mar 30, 2023	SELL	$11.65 - $15.28 $80,583 - $105,691	-6,917 Reduced 75.46%	2,250 $31,000
Q1 2022 May 12, 2022	SELL	$11.65 - $15.28 $80,583 - $105,691	-6,917 Reduced 75.46%	2,250 $32,000
Q4 2021 Jun 21, 2023	BUY	$12.37 - $16.77 $113,395 - $153,730	9,167 New	9,167 $132,000
Q4 2021 Mar 30, 2023	BUY	$12.37 - $16.77 $113,395 - $153,730	9,167 New	9,167 $132,000
Q4 2021 Feb 15, 2022	BUY	$12.37 - $16.77 $113,395 - $153,730	9,167 New	9,167 $133,000

142

45.8M

179K

124K

Ticker BVS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 61,664,200
Market Cap $619M
Description
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.